Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90 | Drug Topics | journal | 0.101 Q4 | 8 | 133 | 1116 | 28 | 8 | 867 | 0.01 | 0.21 |  |
| 89 | Adverse Drug Reaction Bulletin | journal | 0.102 Q4 | 8 | 6 | 18 | 231 | 2 | 18 | 0.08 | 38.50 | |
| 88 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.104 Q4 | 29 | 5 | 9 | 374 | 1 | 3 | 0.11 | 74.80 | |
| 87 | Current Protocols in Pharmacology | journal | 0.105 Q4 | 39 | 20 | 58 | 834 | 5 | 55 | 0.09 | 41.70 | |
| 86 | Pharmacy Times | trade journal | 0.108 Q4 | 8 | 213 | 461 | 702 | 16 | 407 | 0.03 | 3.30 | |
| 85 | U.S. Pharmacist | trade journal | 0.117 Q4 | 12 | 131 | 332 | 2225 | 32 | 311 | 0.10 | 16.98 | |
| 84 | Journal of Applied Research | journal | 0.118 Q4 | 23 | 21 | 90 | 490 | 26 | 82 | 0.31 | 23.33 | |
| 83 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.137 Q4 | 34 | 34 | 95 | 855 | 33 | 95 | 0.22 | 25.15 | |
| 82 | Current Therapeutic Research | journal | 0.139 Q4 | 46 | 40 | 112 | 1194 | 39 | 108 | 0.28 | 29.85 | |
| 81 | Pharmaceutical Chemistry Journal | journal | 0.139 Q4 | 39 | 161 | 489 | 2532 | 98 | 489 | 0.14 | 15.73 | |
| 80 | Proceedings of the Western Pharmacology Society | journal | 0.145 Q4 | 25 | 36 | 114 | 592 | 33 | 114 | 0.40 | 16.44 | |
| 79 | Clinical Research and Regulatory Affairs | journal | 0.147 Q4 | 18 | 12 | 37 | 303 | 11 | 37 | 0.25 | 25.25 | |
| 78 | Journal of Pharmaceutical Finance, Economics and Policy | journal | 0.152 Q4 | 8 | 0 | 52 | 0 | 11 | 40 | 0.13 | 0.00 | |
| 77 | Hospital Pharmacy | journal | 0.155 Q4 | 28 | 157 | 432 | 2002 | 67 | 384 | 0.16 | 12.75 | |
| 76 | Medical Letter on Drugs and Therapeutics | journal | 0.180 Q3 | 22 | 91 | 207 | 510 | 82 | 204 | 0.38 | 5.60 | |
| 75 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.182 Q3 | 40 | 6 | 18 | 0 | 13 | 18 | 0.00 | 0.00 | |
| 74 | National Toxicology Program technical report series | journal | 0.189 | 22 | 2 | 24 | 0 | 24 | 24 | 1.00 | 0.00 | |
| 73 | International Journal of Medicinal Mushrooms | journal | 0.197 Q3 | 41 | 42 | 104 | 1402 | 56 | 103 | 0.48 | 33.38 | |
| 72 | Current Cardiovascular Risk Reports | journal | 0.200 Q3 | 34 | 66 | 155 | 2683 | 29 | 147 | 0.19 | 40.65 | |
| 71 | Journal of Herbal Pharmacotherapy | journal | 0.211 Q3 | 33 | 0 | 64 | 0 | 50 | 62 | 0.44 | 0.00 | |
| 70 | Food and Drug Law Journal | journal | 0.282 Q3 | 23 | 32 | 115 | 5476 | 47 | 115 | 0.44 | 171.13 | |
| 69 | Pharmacopeial Forum (discontinued) | journal | 0.298 Q3 | 20 | 24 | 35 | 218 | 21 | 35 | 0.91 | 9.08 | |
| 68 | Natural Product Communications | journal | 0.311 Q3 | 63 | 340 | 745 | 9227 | 558 | 734 | 0.74 | 27.14 | |
| 67 | Supportive Cancer Therapy | journal | 0.314 Q3 | 15 | 0 | 66 | 0 | 69 | 55 | 1.32 | 0.00 | |
| 66 | Journal of the American Pharmacists Association : JAPhA | journal | 0.375 Q3 | 73 | 133 | 355 | 2734 | 313 | 323 | 0.71 | 20.56 | |
| 65 | Metal-Based Drugs | journal | 0.378 Q3 | 40 | 3 | 23 | 94 | 40 | 21 | 1.74 | 31.33 | |
| 64 | Drug and Chemical Toxicology | journal | 0.389 Q3 | 54 | 57 | 103 | 1903 | 153 | 103 | 1.51 | 33.39 | |
| 63 | Biologicals | journal | 0.426 Q3 | 66 | 72 | 159 | 1336 | 228 | 144 | 1.39 | 18.56 | |
| 62 | Drug Development and Industrial Pharmacy | journal | 0.505 Q3 | 100 | 167 | 421 | 5151 | 544 | 417 | 1.25 | 30.84 | |
| 61 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.512 Q3 | 68 | 88 | 246 | 2977 | 362 | 237 | 1.54 | 33.83 | |
| 60 | American Journal of Therapeutics | journal | 0.579 Q2 | 69 | 104 | 294 | 3290 | 517 | 270 | 1.71 | 31.63 | |
| 59 | Journal of Experimental Therapeutics and Oncology | journal | 0.610 Q2 | 40 | 16 | 78 | 712 | 134 | 77 | 1.53 | 44.50 | |
| 58 | Reading Teacher | journal | 0.610 Q2 | 60 | 80 | 243 | 1594 | 183 | 241 | 0.63 | 19.93 | |
| 57 | Journal of Biopharmaceutical Statistics | journal | 0.642 Q2 | 56 | 80 | 233 | 1455 | 241 | 208 | 1.04 | 18.19 | |
| 56 | American Journal of Health-System Pharmacy | journal | 0.672 Q2 | 107 | 384 | 1302 | 6317 | 1768 | 868 | 1.36 | 16.45 | |
| 55 | Journal of AOAC International | journal | 0.696 Q2 | 100 | 248 | 613 | 5339 | 1030 | 606 | 1.42 | 21.53 | |
| 54 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.741 Q2 | 72 | 86 | 218 | 2478 | 407 | 213 | 1.84 | 28.81 | |
| 53 | Basic and Clinical Pharmacology and Toxicology | journal | 0.758 Q2 | 103 | 134 | 465 | 4864 | 1202 | 458 | 2.47 | 36.30 | |
| 52 | Journal of Pharmacological and Toxicological Methods | journal | 0.771 Q2 | 83 | 57 | 193 | 1887 | 462 | 186 | 2.38 | 33.11 | |
| 51 | Clinical Neuropharmacology | journal | 0.856 Q2 | 85 | 97 | 179 | 2350 | 507 | 165 | 2.80 | 24.23 | |
| 50 | Therapeutic Drug Monitoring | journal | 0.858 Q2 | 102 | 99 | 384 | 3775 | 1060 | 360 | 2.73 | 38.13 | |
| 49 | Bulletin of Mathematical Biology | journal | 0.884 Q2 | 97 | 87 | 324 | 3457 | 657 | 321 | 2.07 | 39.74 | |
| 48 | Steroids | journal | 0.907 Q2 | 114 | 144 | 423 | 5192 | 1194 | 419 | 3.16 | 36.06 | |
| 47 | Microbial Drug Resistance | journal | 0.915 Q2 | 78 | 51 | 134 | 1183 | 293 | 134 | 2.08 | 23.20 | |
| 46 | Anti-Cancer Drugs | journal | 0.941 Q2 | 102 | 132 | 434 | 4194 | 1190 | 431 | 2.62 | 31.77 | |
| 45 | Chirality | journal | 1.040 Q2 | 83 | 150 | 347 | 6302 | 874 | 342 | 2.71 | 42.01 | |
| 44 | Prostaglandins and Other Lipid Mediators | journal | 1.047 Q2 | 86 | 58 | 165 | 2772 | 429 | 163 | 2.74 | 47.79 | |
| 43 | Vascular Pharmacology | journal | 1.049 Q2 | 108 | 79 | 272 | 3287 | 744 | 266 | 2.18 | 41.61 | |
| 42 | Journal of Cardiovascular Pharmacology | journal | 1.063 Q2 | 109 | 146 | 509 | 6660 | 1544 | 495 | 3.13 | 45.62 | |
| 41 | Journal of Biomolecular Screening | journal | 1.067 Q2 | 86 | 117 | 306 | 2914 | 820 | 304 | 2.56 | 24.91 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data